| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1295b545e8d58b12ea27b271771e4510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104a75602f95389da2b22d9f3b832657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2947df8dfabbe625925a07fd7a7422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d6a8c259c57cf723ae58c40af775d35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901141bc3000220a7071c4f5b720d72f |
| publicationDate |
2021-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210099563-A |
| titleOfInvention |
6,7-dihydro-4H-pyrazolo[1,5-A]pyrazine indole-2-carboxamide active against hepatitis B virus (HBV) |
| abstract |
The present invention relates generally to antiviral agents. In particular, the present invention relates to a compound of formula (I) capable of inhibiting protein(s) encoded by hepatitis B virus (HBV) or interfering with the function of the HBV replication cycle, a composition comprising such a compound, inhibiting HBV virus replication It relates to methods for treating or preventing HBV infection, and methods and intermediates for preparing the compounds. |
| priorityDate |
2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |